Pet Healthcare Global Market Report 2025

Pet healthcare involves a comprehensive approach that combines preventive and therapeutic measures to maintain the well-being of pet animals and keep them free from diseases. This approach is instrumental in promoting a healthy pet lifestyle. It encompasses a multifaceted strategy, which includes regular assessments by a veterinarian to evaluate the pet's overall health and assess the potential for illnesses or other health issues.

The primary types of pet healthcare encompass therapeutics and diagnostics. Therapeutics include products such as vaccines, anti-parasitic medications, and feed additives, designed to treat already-infected pets. These therapeutic products cater to various types of animals, including canines, felines, equines, avian pets, and others. They are made available through diverse distribution channels, including retail outlets, e-commerce platforms, and hospital pharmacies, ensuring accessibility for pet owners seeking healthcare solutions for their animals.

The pet healthcare market research report is one of a series of new reports from The Business Research Company that provides pet healthcare market statistics, including pet healthcare industry global market size, regional shares, competitors with a pet healthcare market share, detailed pet healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the pet healthcare industry. This pet healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pet healthcare market size has grown strongly in recent years. It will grow from $253.75 billion in 2024 to $269.63 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to pet humanization trend, veterinary advancements, changing consumer lifestyles, economic prosperity, regulatory changes.

The pet healthcare market size is expected to see strong growth in the next few years. It will grow to $385.45 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing aging pet population, rise in pet adoption, focus on preventive care, economic trends, advancements in veterinary science. Major trends in the forecast period include pharmaceutical innovations for pet health, personalized pet healthcare plans, e-commerce growth in pet medications, increased focus on mental health, preventive dental care for pets.

The increasing pet ownership is anticipated to drive the growth of the pet healthcare market in the future. Rising pet ownership refers to the growing number of households that have pets, indicating a trend where individuals and families opt to include animals as companions in their lives. This trend is fueled by the emotional benefits pets provide, such as reducing stress and loneliness, as well as lifestyle changes that enable more people to devote time to animal care. Pet healthcare is essential to this rise in pet ownership, as it ensures the well-being and longevity of pets through preventive care and offers health education that assists new pet owners in making informed choices about their pets' care. For instance, in August 2024, The World Animal Foundation reported that sixty-six percent of U.S. households, or 86.9 million homes, own a pet. Dogs are the most popular pets in the U.S., with 65.1 million households having a dog, followed by cats in 46.5 million households and freshwater fish in 11.1 million households. Millennials make up the largest segment of pet owners at 33%, followed by Gen X at 25% and baby boomers at 24%. In 2022, Americans spent $136.8 billion on their pets, marking an increase of nearly 11% from 2021, when spending reached $123.6 billion. Thus, the rise in pet ownership is propelling the growth of the pet healthcare market.

The anticipated increase in the pet population is expected to be a significant driver of the growth in the pet healthcare market in the future. The pet population refers to the total number of domesticated animals kept as pets by individuals or households within a specific geographic area. Pet health products play a crucial role in sustaining and enhancing the well-being of the growing pet population. These products provide preventive care, therapeutic solutions, and nutritional support, contributing to overall pet health and longevity. As of October 2023, data from the European Pet Food Industry Federation (FEDIAF), a UK-based trade association, revealed an 11% growth in the European pet population in 2022, with a total of 340 million pets, primarily comprised of 127 million cats and 104 million dogs. This substantial increase in the pet population underscores the rising demand for pet healthcare products, thereby driving the growth of the pet healthcare market.

The pet healthcare market is witnessing a significant trend towards technological advancements, with major companies strategically introducing innovative digital platforms to enhance their market positioning. A notable example is the October 2023 launch of Zoonivet by Cargill Incorporated, a prominent US-based company. This pet health-focused digital platform is specifically designed to offer convenient and accessible veterinary care through e-consultations. Zoonivet aims to streamline pet healthcare by facilitating remote video consultations between pet parents and qualified veterinarians, addressing primary healthcare needs in a simplified and efficient manner. This strategic move reflects the company's commitment to staying competitive in the evolving landscape of pet healthcare.

Major companies are increasingly directing their efforts towards the implementation of pet biobanks as a strategic means to attain a competitive advantage. A pet biobank serves as a specialized facility dedicated to the storage and management of biological samples, including tissue, blood, or DNA, sourced from animals, predominantly pets. Notably, in June 2022, Mars Petcare, a Belgium-based industry leader, introduced the groundbreaking MARS PETCARE BIOBANK, establishing itself as the world's pioneer in this domain. The primary objective of this pioneering initiative is to catalyze advancements in disease diagnosis and prevention within the realm of pet healthcare. By facilitating the storage of comprehensive biological data, the MARS PETCARE BIOBANK seeks to enhance the understanding of pet health and diseases, thereby enabling scientists and veterinarians to spearhead innovation in personalized healthcare solutions for individual pets. This strategic move underscores Mars Petcare's commitment to driving transformative breakthroughs in the field of pet healthcare.

In December 2023, Zenex Animal Health, an animal health company based in India, successfully acquired Ayurveda for an undisclosed sum. This strategic acquisition is anticipated to enhance Zenex's product portfolio by incorporating herbal offerings, thereby improving the overall quality of its animal health products. Ayurvet, an India-based pet healthcare company, is known for its specialization in providing natural and safe Ayurvedic and herbal medicines tailored for pets. The integration of Ayurveda into Zenex Animal Health's operations represents a strategic move to further diversify and enhance the company's capabilities in the animal health sector.

Major companies operating in the pet healthcare market include Nestle SA, Merck & Co Inc., Mars Inc., Indian Immunologicals Limited, Boehringer Ingelheim International GmbH, Colgate-Palmolive Company, Chewy Inc., Zoetis Inc., Petco Animal Supplies Inc., VCA Animal Hospitals Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Royal Canin, Ceva Sante Animale, Phibro Animal Health Corporation, Trupanion, Vetoquinol S.A., Norbrook Laboratories Ltd., Heska Corporation, Biogenesis Bago SA, Pumpkin Insurance Services Inc., PetFirst Healthcare LLC, Embark Veterinary Inc., Agrolabo SpA, Bayer Animal Health GmbH, Bioniche Animal Health Canada Inc., Novartis Animal Health US Inc.

North America was the largest region in the pet healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global pet healthcare market report during the forecast period. The regions covered in the pet healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pet healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pet healthcare market consists of sales of pet healthcare diagnostic tools, medicines and preventive care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pet Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pet healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pet healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pet healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Therapeutics; Diagnostics
• 2) By Animal Type: Canine; Feline; Equine; Avian; Other Animals
• 3) By Distribution Channel: Retail; E-commerce; Hospital Pharmacies
• Subsegments:
• 1) By Therapeutics: Vaccines; Anti-infective Drugs; Anti-inflammatory Drugs; Pain Management Medications; Parasiticides; Nutraceuticals
• 2) By Diagnostics: Laboratory Diagnostics; Imaging Diagnostics; Point-of-Care Testing; Genetic Testing; Microbiome Testing
• Companies Mentioned: Nestle SA; Merck & Co Inc.; Mars Inc.; Indian Immunologicals Limited; Boehringer Ingelheim International GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.